New BIO leader McMurry-Heath to focus on patients and innovation

BIO is looking to its new CEO and President, Michelle McMurry-Heath, to serve as a new face and voice for the industry, and to refocus the organization on patients and on creating the innovations they need.

McMurry-Heath is taking on the role at a time when the COVID-19 pandemic has focused the world’s attention on the biopharma industry, and the public is hungry for leaders who can speak about science and medicine with credibility, empathy and authenticity. ...